Discover Ankush Bajaj's expert stock picks for Monday, 26 May. Get insights into top performing stocks and informed ...

Cidara Therapeutics' CD388 is aimed at providing universal protection with a single yearly dose for each flu season. See why ...

Planning to swing by the Bullseye this Monday? Here's what to know about Memorial Day store hours before you go.

Reacting to the Q3 FY25 results, TD Cowen analyst Shaul Eyal reiterated a buy rating on Palo Alto stock with a price target ...

Looking ahead, Target slashed its full-year earnings guidance, taking it to a range of $7 to $9 per share from a prior outlook of $8.80 to $9.80. Meanwhile, it's now looking for sales to decline by ...

The project, to be built by the US and UAE, will take place in collaboration with the Emirati firm G42. It will span 10 ...

Discover Target's (NYSE: TGT) growth opportunities, from Circle 360 loyalty and Roundel ad revenue to store-as-hub logistics, ...

Target should eventually return to growth, though the stock is likely to be dead money until the company can deliver some ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $88.33, a high ...

Target sales plunged in the first quarter amid concerns about Trump's tariffs, inflation and backlash to its pull back on DEI ...

Apple Inc. has become a frequent target for attacks by President Donald Trump, a factor that has held the stock back as other ...

Target (NYSE: TGT) reported quarterly sales declines compared to the previous year and downgraded its outlook for the rest of 2025. Where to invest $1,000 right now? Our analyst team just revealed ...